Can selective serotonin reuptake inhibitor (SSRI) withdrawal still be considered a cause of symptoms in a patient 3 months after discontinuing medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SSRI Withdrawal at 3 Months Post-Discontinuation

SSRI withdrawal symptoms are highly unlikely to be the cause of symptoms 3 months after medication discontinuation, as the typical withdrawal syndrome resolves within 1-3 weeks, with symptoms rarely persisting beyond this timeframe. 1, 2, 3

Timeline of SSRI Withdrawal Syndrome

The evidence consistently demonstrates a predictable temporal pattern for SSRI discontinuation symptoms:

  • Onset: Symptoms typically begin within 1 week (often within 24-48 hours) of stopping the medication or reducing the dose 4, 5, 2, 3

  • Duration: The withdrawal syndrome is characteristically self-limiting, with most symptoms resolving spontaneously within 1-3 weeks 4, 1, 2, 3

  • Resolution: Symptoms are rapidly extinguished (within 48 hours) if the SSRI is reinstituted 2, 6

Why 3 Months Makes Withdrawal Unlikely

At 3 months post-discontinuation, you are well beyond the expected window for SSRI withdrawal:

  • The American Academy of Child and Adolescent Psychiatry specifically notes that patients with mood and anxiety disorders may experience return of symptoms "weeks to months" after their last dose, but this represents relapse of the underlying condition, not withdrawal 4

  • The distinction is critical: withdrawal symptoms improve spontaneously over 1-2 weeks, while return of the original disorder develops more slowly (after 2-6 weeks) and does not improve without treatment 5

Alternative Explanations to Consider

At 3 months, current symptoms are far more likely to represent:

  • Relapse of the underlying psychiatric condition that was being treated with the SSRI 4, 5

  • A new or unrelated medical condition that requires separate evaluation 3

  • Protracted withdrawal (extremely rare and poorly documented in the literature for SSRIs) 1

Clinical Caveats

While the evidence strongly suggests withdrawal is not the culprit at 3 months, be aware of these nuances:

  • Some case reports describe "late onset and/or longer persistence of disturbances" as possible variations, though these are exceptional rather than typical 1

  • The literature acknowledges that "many variations are possible" in presentation, but does not provide robust evidence for symptoms persisting beyond several weeks 1

  • Common pitfall: Misidentifying relapse of the original psychiatric disorder as prolonged withdrawal, which can lead to inappropriate management 1, 6

Recommended Clinical Approach

Focus your evaluation on:

  • Assessing for recurrence of the original psychiatric condition that warranted SSRI treatment initially 4

  • Conducting a thorough review of current symptoms to determine if they match the patient's pre-treatment presentation versus the characteristic withdrawal syndrome (dizziness, nausea, sensory disturbances, flu-like symptoms) 7, 1, 3

  • Evaluating for new medical or psychiatric conditions unrelated to the prior SSRI use 3

Do not attribute symptoms at 3 months to SSRI withdrawal unless you have exhausted other diagnostic possibilities and have documented an exceptionally atypical presentation 1, 2, 3

References

Research

The SSRI discontinuation syndrome.

Journal of psychopharmacology (Oxford, England), 1998

Research

Antidepressant discontinuation syndrome.

American family physician, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Citalopram Withdrawal Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Citalopram Discontinuation and Sleepwalking

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What else could be causing symptoms in a patient with a history of SSRI discontinuation syndrome and impaired fasting glucose, previously treated with escitalopram?
Can a patient still experience symptoms, such as tingling in the lower legs, arms, and back, 3 months after discontinuing Selective Serotonin Reuptake Inhibitor (SSRI) medication?
What could be causing tingling in the lower legs of a patient with a history of anxiety, who recently discontinued SSRI (Selective Serotonin Reuptake Inhibitor) medication after 4 months, and previously experienced side effects including paresthesia (energy flowing) in the arms, urticaria (hives) on the face, and insomnia while on the medication?
What is the duration of Selective Serotonin Reuptake Inhibitor (SSRI) discontinuation syndrome?
Does discontinuation of Wellbutrin (bupropion) cause headaches?
What adjustments can be made to the treatment plan for a patient with Attention Deficit Hyperactivity Disorder (ADHD) who is currently taking Adderall XR (amphetamine and dextroamphetamine) 15mg, experiencing itching and increased anxiety, but has improved focus, and has a past history of taking Strattera (atomoxetine) with minimal benefit but reported feeling calm?
What is the recommended oseltamivir (Tamiflu) prophylaxis regimen for high-risk patients, including the elderly, young children, and those with chronic health conditions, following exposure to influenza?
What is the recommended prophylaxis for a patient exposed to blood-borne pathogens with a risk of Hepatitis C (HCV) transmission?
What is the most effective immunotherapy, Intravenous Immunoglobulin (IVIG) or Therapeutic Plasma Exchange (TPE), for a patient with Myasthenia Gravis (MG)?
What is the safest muscle relaxer for a patient with atrial fibrillation (AFib)?
What is the best management approach for a patient with acute on chronic kidney injury, possibly due to underlying conditions like diabetes or hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.